Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Panel recommends leadership overhaul at FDA food program

Por: The Hill Health December 08, 2022

thumbnail

The Food and Drug Administration (FDA) needs major restructuring to put a single person in charge of its food safety program, according to an outside review of the agency commissioned in the wake of the infant formula crisis. The FDA has come under fire from lawmakers and food safety advocates for the way it handled an infant formula shortage that left parents scrambling. The agency has long faced criticism that it doesn’t give enough... + full article



Similar News

Health Care — Review recommends changes for FDA food program

The Hill USA Health December 08, 2022

thumbnailLeave it to Ticketmaster to unite Republicans and Democrats: Bipartisan members of the House Energy and Commerce Committee want a briefing about the company’s Taylor Swift debacle.   Today in health, lawmakers are on the verge of getting rid of the Pentagon’s COVID-19... + más

ALS drug wins FDA approval despite questionable data | ABC News

ALS drug wins FDA approval despite questionable data | WPLG Local 10


FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth

CNBC USA Health October 19, 2022

thumbnailAn advisory panel to the Food and Drug Administration voted Wednesday to take a drug intended to prevent premature births off the market, saying that it remains doubtful that the drug works.The recommendation, in a 14-1 vote, from the agency's Obstetrics, Reproductive and... + más

FDA panel backs removal of unproven pregnancy drug | WPLG Local 10

ALS drug wins FDA approval despite questionable data | ABC News


ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | WPLG Local 10


ALS drug wins FDA approval despite questionable data

WPLG Local 10 USA Politics September 30, 2022

thumbnailWASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


ALS drug wins FDA approval despite questionable data

Associated Press USA Science September 30, 2022

thumbnailWASHINGTON (AP) — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


FDA concedes delays in response to baby formula shortage

WPLG Local 10 USA Health September 24, 2022

thumbnailWASHINGTON – The Food and Drug Administration acknowledged Tuesday that its response to the U.S. was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency offers its first formal... + más

FDA concedes delays in response to baby formula shortage | ABC News

‘If the FDA is expected to do more, it needs more’: FDA investigation into baby-formula crisis points to its own shortcomings. But shortages persist. | MarketWatch


FDA concedes delays in response to baby formula shortage

Associated Press USA Politics September 21, 2022

thumbnailWASHINGTON (AP) — The Food and Drug Administration acknowledged Tuesday that its response to the U.S. was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency offers its first... + más

FDA concedes delays in response to baby formula shortage | ABC News

Internal FDA report on infant formula crisis details shortfalls in response | ABC News



About iurex | Privacy Policy | Disclaimer |